中国学者近期发表的论文
1.	Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling. Author: Chen C1, Tian A2, Zhao M3, Ma X4. Journal: Cancer Gene Ther. 2019 Mar;26(3-4):83-93. doi: 10.1038/s41417-018-0041-2. Epub 2018 Aug 24.    PubMed      DOI
2.	High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy. Author: Zhang J1, Zhang L2, Cui H3, Zhang X1, Zhang G1, Yang X1, Yang S1, Zhang Z4, Wang J1, Hu K1, Shi J5, Ke X1, Fu L6. Journal: Cancer Gene Ther. 2019 May;26(5-6):119-127. doi: 10.1038/s41417-018-0044-z. Epub 2018 Sep 4.    PubMed      DOI
3.	GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2. Author: Ye Y1, Song YN1, He SF1, Zhuang JH1, Wang GY1, Xia W2. Journal: Cancer Gene Ther. 2019 Mar;26(3-4):103-113. doi: 10.1038/s41417-018-0045-y. Epub 2018 Sep 4.    PubMed      DOI
4.	The effect of gene therapy on postoperative recurrence of small hepatocellular carcinoma (less than 5cm). Author: Meng J1, Zhang JG1, Du ST1, Li N2. Journal: Cancer Gene Ther. 2019 Mar;26(3-4):114-117. doi: 10.1038/s41417-018-0043-0. Epub 2018 Sep 7.    PubMed      DOI
5.	Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway. Author: Sun L1, Liang H1, Yu W1, Jin X2. Journal: Cancer Gene Ther. 2019 May;26(5-6):136-144. doi: 10.1038/s41417-018-0053-y. Epub 2018 Oct 26.    PubMed      DOI
6.	BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction. Author: Yao Z1, Yang S2, Zhao H3, Yang H4, Jiang X5. Journal: Cancer Gene Ther. 2019 Feb 1. doi: 10.1038/s41417-018-0068-4. [Epub ahead of print]    PubMed      DOI
7.	c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma. Author: Li S1, Zhang S2, Chen J3. Journal: Cancer Gene Ther. 2019 Jan 4. doi: 10.1038/s41417-018-0072-8. [Epub ahead of print]    PubMed      DOI
8.	High expression of UBE2T predicts poor prognosis and survival in multiple myeloma. Author: Zhang W1, Zhang Y2, Yang Z1, Liu X3, Yang P1, Wang J1, Hu K1, He X4, Zhang X5, Jing H6. Journal: Cancer Gene Ther. 2019 Jan 9. doi: 10.1038/s41417-018-0070-x. [Epub ahead of print]    PubMed      DOI
9.	Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma. Author: Bao F1, Wan W1, He T2, Qi F2, Liu G2, Hu K1, Lu XA2, Yang P1, Dong F1, Wang J1, Jing H3. Journal: Cancer Gene Ther. 2019 Jan 9. doi: 10.1038/s41417-018-0073-7. [Epub ahead of print]    PubMed      DOI
10.	Prognosis value of RBBP8 expression in plasma cell myeloma. Author: Zhang W1, Song Y2, He X3, Liu X4, Zhang Y5, Yang Z1, Yang P1, Wang J1, Hu K1, Liu W4, Zhang X6, Yuan X7, Jing H8. Journal: Cancer Gene Ther. 2019 Jan 9. doi: 10.1038/s41417-018-0069-3. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore NATURE REVIEWS DRUG DISCOVERY 289 9.90 NATURE BIOTECHNOLOGY 399 11.51 TRENDS IN BIOTECHNOLOGY 195 10.15 BIOTECHNOLOGY ADVANCES 161 13.83 MOLECULAR THERAPY 158 6.05 PLANT BIOTECHNOLOGY JOURNAL 96 6.88 CRITICAL REVIEWS IN BIOTECHNOLOGY 79 6.91 METABOLIC ENGINEERING 101 8.78 GENOMICS 135 2.77 STEM CELLS 205 5.47

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 286006 CANCER RESEARCH 163640 International Journal of Nanomedicine 162050 Molecular Medicine Reports 161918 CANCER LETTERS 157137 JOURNAL OF ETHNOPHARMACOLOGY 138967 BIOMEDICINE & PHARMACOTHERAPY 136940 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133577 Theranostics 132881 International Journal of Environmental Research and Public Health 131239